retatrutide clinical trials sign up Eli Lilly infiltrates anti-obesity market as Phase III trial for begins retatrutide clinical trial sign up

What About Compounding Pharmacies

For any compound that will be used for decades in chronic disease, a dedicated MACE (major adverse cardiovascular events) trial is required

There is also a trial specifically testing whether retatrutide prevents heart attacks and strokes (TRIUMPH-3, 1,800 people), and a head-to-head trial comparing retatrutide directly against tirzepatide (the active ingredient in Zepbound) under identical conditions (NCT06662383, 800 patients)

Not based on current data

This pathway is designed for people in immediate medical danger, for example someone whose obesity is causing severe heart failure or who cannot breathe properly because of their weight